CARDIOVASCULAR SYSTEMS, INC.

CSIIUnited States

31 filed reports · 362 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$236M

FY2022 · to Jun 30, 2022

down −8.8% vs $259M

10-K

Net income

-$36.9M

FY2022 · to Jun 30, 2022

a year earlier: -$13.4M

10-K

Operating income

-$35.8M

FY2022 · to Jun 30, 2022

a year earlier: -$11.9M

10-K

Latest quarter

Revenue

$61.5M

Q2 FY2023 · to Dec 31, 2022

up +3.9% vs $59.1M

10-Q

Net income

-$7.89M

Q2 FY2023 · to Dec 31, 2022

a year earlier: -$8.97M

10-Q

Operating income

-$8.53M

Q2 FY2023 · to Dec 31, 2022

a year earlier: -$8.56M

10-Q

Filed reports

31 reports · Jun 2015 to Dec 2022

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR233,229Sep 2015 to Dec 2022
Annual · 10-KSEC EDGAR82,884Jun 2015 to Jun 2022

Documents

PeriodTypePeriod endPublishedFactsSource
FY2023 Q210-Q2022-12-312023-02-09325Open
FY2023 Q110-Q2022-09-302022-11-03175Open
FY202210-K2022-06-302022-08-18607Open
FY2022 Q310-Q2022-03-312022-05-05217Open
FY2022 Q210-Q2021-12-312022-02-03129Open
FY2022 Q110-Q2021-09-302021-11-09129Open
FY202110-K2021-06-302021-08-19309Open
FY2021 Q310-Q2021-03-312021-05-06161Open
FY2021 Q210-Q2020-12-312021-02-04125Open
FY2021 Q110-Q2020-09-302020-11-05127Open
FY202010-K2020-06-302020-08-20348Open
FY2020 Q310-Q2020-03-312020-05-07146Open

Financial data

362 concepts · 6,113 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial360 concepts · 5,993 facts · Jul 2012 to Dec 2022

  • Gross profit (US GAAP)48 · Jun 2013 to Dec 2022
  • Net income loss48 · Jun 2013 to Dec 2022
  • Revenue48 · Jun 2013 to Dec 2022
  • Cash and cash equivalents at carrying value46 · Jun 2013 to Dec 2022
  • Amortization of intangible assets44 · Jun 2013 to Dec 2022
  • Increase decrease in accounts payable44 · Jun 2013 to Dec 2022
  • Increase decrease in accounts receivable44 · Jun 2013 to Dec 2022
  • Increase decrease in accrued liabilities and other operating liabilities44 · Jun 2013 to Dec 2022
  • Increase decrease in inventories44 · Jun 2013 to Dec 2022
  • Increase decrease in prepaid deferred expense and other assets44 · Jun 2013 to Dec 2022
  • Net cash provided by used in financing activities44 · Jun 2013 to Dec 2022
  • Net cash provided by used in investing activities44 · Jun 2013 to Dec 2022
  • Net cash provided by used in operating activities44 · Jun 2013 to Dec 2022
  • Nonoperating income expense44 · Jun 2013 to Dec 2022
  • Operating expenses (US GAAP)44 · Jun 2013 to Dec 2022
  • Operating income loss44 · Jun 2013 to Dec 2022
  • Payments to acquire property plant and equipment44 · Jun 2013 to Dec 2022
  • Research and development expense44 · Jun 2013 to Dec 2022
  • Selling general and administrative expense44 · Jun 2013 to Dec 2022
  • Share based compensation44 · Jun 2013 to Dec 2022
  • Comprehensive income net of tax43 · Jun 2013 to Dec 2022
  • Stockholders equity (US GAAP)43 · Jun 2013 to Dec 2022
  • Other comprehensive income unrealized holding gain loss on securities arising during period net of tax42 · Jun 2014 to Dec 2022
  • Accounts payable current41 · Jun 2014 to Dec 2022

Geography1 concept · 60 facts · Jun 2017 to Dec 2022

  • Revenue60 · Jun 2017 to Dec 2022

Product1 concept · 60 facts · Jun 2017 to Dec 2022

  • Revenue60 · Jun 2017 to Dec 2022

Segments

120 facts

Figures broken down by business line, region, product or another axis the company reports on.

Product or servicesrt:ProductOrServiceAxis2 members · 56 facts

  • Coronary28 · Jun 2017 to Dec 2022
  • Peripheral28 · Jun 2017 to Dec 2022

Statement geographicalsrt:StatementGeographicalAxis2 members · 56 facts

  • International28 · Jun 2017 to Dec 2022
  • United States28 · Jun 2017 to Dec 2022

Product or serviceus-gaap:ProductOrServiceAxis2 members · 4 facts

  • Coronary2 · Sep 2017 to Sep 2018
  • Peripheral2 · Sep 2017 to Sep 2018

Statement geographicalus-gaap:StatementGeographicalAxis2 members · 4 facts

  • International2 · Sep 2017 to Sep 2018
  • United States2 · Sep 2017 to Sep 2018

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of CARDIOVASCULAR SYSTEMS, INC. (CSII) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.

CARDIOVASCULAR SYSTEMS, INC. (CSII): FY2022 revenue $236M · FactIQ